
### [NCIT:C27881](http://purl.obolibrary.org/obo/NCIT_C27881)
**Label:** Transitional Cell Intraepithelial Neoplasia

**Subclasses:** [NCIT:C7517](http://purl.obolibrary.org/obo/NCIT_C7517) (Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C27882](http://purl.obolibrary.org/obo/NCIT_C27882) (Bladder Low Grade Intraurothelial Neoplasia), [NCIT:C7518](http://purl.obolibrary.org/obo/NCIT_C7518) (Stage 0is Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C4597](http://purl.obolibrary.org/obo/NCIT_C4597) (Stage 0is Renal Pelvis Urothelial Carcinoma), [NCIT:C6149](http://purl.obolibrary.org/obo/NCIT_C6149) (Stage 0 Ureter Urothelial Carcinoma), [NCIT:C27880](http://purl.obolibrary.org/obo/NCIT_C27880) (Intraurothelial Neoplasia), [NCIT:C6203](http://purl.obolibrary.org/obo/NCIT_C6203) (Stage 0a Ureter Urothelial Carcinoma), [NCIT:C3644](http://purl.obolibrary.org/obo/NCIT_C3644) (Stage 0is Bladder Urothelial Carcinoma), [NCIT:C4116](http://purl.obolibrary.org/obo/NCIT_C4116) (Stage 0 Transitional Cell Carcinoma), [NCIT:C6188](http://purl.obolibrary.org/obo/NCIT_C6188) (Stage 0 Bladder Urothelial Carcinoma), [NCIT:C6202](http://purl.obolibrary.org/obo/NCIT_C6202) (Stage 0a Renal Pelvis Urothelial Carcinoma), [NCIT:C9267](http://purl.obolibrary.org/obo/NCIT_C9267) (Stage 0a Bladder Urothelial Carcinoma), [NCIT:C27876](http://purl.obolibrary.org/obo/NCIT_C27876) (Non-Invasive Bladder Papillary Urothelial Carcinoma, High Grade), [NCIT:C39850](http://purl.obolibrary.org/obo/NCIT_C39850) (Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C37266](http://purl.obolibrary.org/obo/NCIT_C37266) (Bladder Flat Intraepithelial Lesion), [NCIT:C6193](http://purl.obolibrary.org/obo/NCIT_C6193) (Stage 0 Renal Pelvis Urothelial Carcinoma), [NCIT:C4529](http://purl.obolibrary.org/obo/NCIT_C4529) (Stage 0is Ureter Urothelial Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C39716](http://purl.obolibrary.org/obo/NCIT_C39716) (EGFR Protein Overexpression) 53.85%
- [NCIT:C36639](http://purl.obolibrary.org/obo/NCIT_C36639) (ERBB2 Protein Overexpression) 53.85%
- [NCIT:C36548](http://purl.obolibrary.org/obo/NCIT_C36548) (Loss of Chromosome 2q) 53.85%
- [NCIT:C36516](http://purl.obolibrary.org/obo/NCIT_C36516) (Loss of Chromosome 10q) 53.85%
- [NCIT:C36496](http://purl.obolibrary.org/obo/NCIT_C36496) (Loss of Chromosome 18q) 53.85%
- [NCIT:C36489](http://purl.obolibrary.org/obo/NCIT_C36489) (Gain of Chromosome 5p) 53.85%
- [NCIT:C36480](http://purl.obolibrary.org/obo/NCIT_C36480) (Gain of Chromosome 20q) 53.85%
- [NCIT:C36329](http://purl.obolibrary.org/obo/NCIT_C36329) (TP53 Gene Inactivation) 53.85%
- [NCIT:C27712](http://purl.obolibrary.org/obo/NCIT_C27712) (Loss of Chromosome 5q) 53.85%
- [NCIT:C12866](http://purl.obolibrary.org/obo/NCIT_C12866) (Transitional Cell) 53.85%
- [CL:1001428](http://purl.obolibrary.org/obo/CL_1001428) (bladder urothelial cell) 53.85%
- [CL:1001319](http://purl.obolibrary.org/obo/CL_1001319) (bladder cell) 53.85%
- [CL:1000600](http://purl.obolibrary.org/obo/CL_1000600) (lower urinary tract cell) 53.85%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and [CL:1001319](http://purl.obolibrary.org/obo/CL_1001319) (bladder cell) 53.85%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and [CL:1000600](http://purl.obolibrary.org/obo/CL_1000600) (lower urinary tract cell) 53.85%


